Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A randomized double blinded phase 3 study demonstrates clinical equivalence of CT-P-13 to infliximab when co-administered with methotrexate in patients with active rheumatoid arthritis
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 유대현 | - |
| dc.date.accessioned | 2021-08-03T14:51:23Z | - |
| dc.date.available | 2021-08-03T14:51:23Z | - |
| dc.date.issued | 2012-06-08 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/51533 | - |
| dc.title | A randomized double blinded phase 3 study demonstrates clinical equivalence of CT-P-13 to infliximab when co-administered with methotrexate in patients with active rheumatoid arthritis | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | EULAR 2012(Annual European Congress of Rheumatology) | - |
| dc.citation.conferencePlace | Berlin | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.